Neurological conditions represent an important and evolving area of cannabinoid medicine. In this session, Professor Mike Barnes explores the potential role of cannabis-based medicines in managing neurological symptoms and considers their application across a range of specific disorders. The session examines spasticity and multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Tourette’s syndrome, choreiform and dystonic conditions, glioblastoma, and traumatic brain injury. It considers where cannabinoid therapy may have a role, the clinical evidence supporting its use, and areas where the evidence remains preliminary or uncertain. Common neurological symptoms including pain, anxiety, sleep disturbance and epilepsy are addressed in greater depth in dedicated sessions elsewhere in the course. Presented by Professor Mike Barnes is a consultant neurologist at the University of Newcastle in the UK. He is an internationally recognised clinician and educator in medical cannabis. This session provides an expert led, practical, evidence-informed overview of cannabinoid therapy within todays neurological practice.